Vaccinex Inc (VCNX)
5.40
+0.25
(+4.85%)
USD |
NASDAQ |
May 24, 16:00
5.51
+0.11
(+2.04%)
After-Hours: 20:00
Vaccinex Shareholders Equity (Quarterly): 2.655M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.655M |
December 31, 2023 | -2.311M |
September 30, 2023 | -3.869M |
June 30, 2023 | -0.423M |
March 31, 2023 | 2.40M |
December 31, 2022 | 5.193M |
September 30, 2022 | 6.318M |
June 30, 2022 | 10.94M |
March 31, 2022 | 16.19M |
December 31, 2021 | 7.412M |
September 30, 2021 | 11.89M |
June 30, 2021 | 16.94M |
March 31, 2021 | 0.818M |
Date | Value |
---|---|
December 31, 2020 | -26.58M |
September 30, 2020 | -20.20M |
June 30, 2020 | -29.54M |
March 31, 2020 | -25.70M |
December 31, 2019 | -26.24M |
September 30, 2019 | -20.05M |
June 30, 2019 | -26.34M |
March 31, 2019 | -17.63M |
December 31, 2018 | -8.621M |
September 30, 2018 | -0.218M |
June 30, 2018 | -28.11M |
March 31, 2018 | -21.56M |
December 31, 2017 | -13.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-29.54M
Minimum
Jun 2020
16.94M
Maximum
Jun 2021
-5.025M
Average
0.1975M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 7.367M |
Total Liabilities (Quarterly) | 4.712M |
Debt to Equity Ratio | 0.0309 |
Current Ratio | 1.520 |
Net Debt Paydown Yield | 0.16% |